306 related articles for article (PubMed ID: 26297533)
1. Optimizing Treatment of Elderly COPD Patients: What Role for Inhaled Corticosteroids?
Rossi AP; Zanardi E; Zamboni M; Rossi A
Drugs Aging; 2015 Sep; 32(9):679-87. PubMed ID: 26297533
[TBL] [Abstract][Full Text] [Related]
2. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
[TBL] [Abstract][Full Text] [Related]
3. Inhaled corticosteroids in COPD: friend or foe?
Agusti A; Fabbri LM; Singh D; Vestbo J; Celli B; Franssen FME; Rabe KF; Papi A
Eur Respir J; 2018 Dec; 52(6):. PubMed ID: 30190269
[TBL] [Abstract][Full Text] [Related]
4. Inhaled corticosteroids in COPD: the clinical evidence.
Ernst P; Saad N; Suissa S
Eur Respir J; 2015 Feb; 45(2):525-37. PubMed ID: 25537556
[TBL] [Abstract][Full Text] [Related]
5. Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine.
Contoli M; Corsico AG; Santus P; Di Marco F; Braido F; Rogliani P; Calzetta L; Scichilone N
COPD; 2017 Dec; 14(6):641-647. PubMed ID: 29116901
[TBL] [Abstract][Full Text] [Related]
6. Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD).
Chalmers JD; Poole C; Webster S; Tebboth A; Dickinson S; Gayle A
Respir Res; 2018 Apr; 19(1):63. PubMed ID: 29642882
[TBL] [Abstract][Full Text] [Related]
7. The Effect on Total Mortality of Adding Inhaled Corticosteroids to Long-Acting Bronchodilators for COPD: A Real Practice Analysis in Italy.
Di Martino M; Agabiti N; Cascini S; Kirchmayer U; Bauleo L; Fusco D; Belleudi V; Pinnarelli L; Voci C; Patorno E; Pistelli R; Davoli M;
COPD; 2016 Jun; 13(3):293-302. PubMed ID: 26514912
[TBL] [Abstract][Full Text] [Related]
8. Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD.
Yamauchi Y; Yasunaga H; Hasegawa W; Sakamoto Y; Takeshima H; Jo T; Matsui H; Fushimi K; Nagase T
Int J Chron Obstruct Pulmon Dis; 2016; 11():1403-11. PubMed ID: 27382276
[TBL] [Abstract][Full Text] [Related]
9. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
[TBL] [Abstract][Full Text] [Related]
10. Inhaled treatment of COPD: a Delphi consensus statement.
Ninane V; Corhay JL; Germonpré P; Janssens W; Joos GF; Liistro G; Vincken W; Gurdain S; Vanvlasselaer E; Lehouck A
Int J Chron Obstruct Pulmon Dis; 2017; 12():793-801. PubMed ID: 28293106
[TBL] [Abstract][Full Text] [Related]
11. Inappropriate inhaled corticosteroid prescribing in chronic obstructive pulmonary disease patients.
Harrison A; Borg B; Thompson B; Hew M; Dabscheck E
Intern Med J; 2017 Nov; 47(11):1310-1313. PubMed ID: 29105270
[TBL] [Abstract][Full Text] [Related]
12. Inhaled Corticosteroids for Chronic Obstructive Pulmonary Disease--The Shifting Treatment Paradigm.
Wilkie M; Finch S; Schembri S
COPD; 2015; 12(5):582-90. PubMed ID: 25774769
[TBL] [Abstract][Full Text] [Related]
13. Inhaled Corticosteroids in Subjects with Chronic Obstructive Pulmonary Disease: An Old, Unfinished History.
Melani AS; Croce S; Fabbri G; Messina M; Bargagli E
Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397432
[TBL] [Abstract][Full Text] [Related]
14. Role of Long-Acting Muscarinic Antagonist/Long-Acting β
Petite SE
Ann Pharmacother; 2017 Aug; 51(8):696-705. PubMed ID: 28410560
[TBL] [Abstract][Full Text] [Related]
15. Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO).
Rossi A; Guerriero M; Corrado A;
Respir Res; 2014 Jul; 15(1):77. PubMed ID: 25005873
[TBL] [Abstract][Full Text] [Related]
16. Comparative Effectiveness of Long-Acting Beta
Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA
Pharmacotherapy; 2017 Apr; 37(4):447-455. PubMed ID: 28226405
[TBL] [Abstract][Full Text] [Related]
17. The Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.
Gillissen A; Haidl P; Khlhäufl M; Kroegel K; Voshaar T; Gessner C
Dtsch Arztebl Int; 2016 May; 113(18):311-6. PubMed ID: 27215595
[TBL] [Abstract][Full Text] [Related]
18. [The place of inhaled corticosteroids in COPD].
Chinet T; Dumoulin J; Honore I; Braun JM; Couderc LJ; Febvre M; Mangiapan G; Maurer C; Serrier P; Soyez F; Terrioux P; Jebrak G
Rev Mal Respir; 2016 Dec; 33(10):877-891. PubMed ID: 26831345
[TBL] [Abstract][Full Text] [Related]
19. [Bronchodilators in COPD: latest recommendations, recent data and perspectives].
Roche N
Presse Med; 2004 Jan; 33(2):111-8. PubMed ID: 15026706
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein as a biomarker of response to inhaled corticosteroids among patients with COPD.
Oshagbemi OA; Franssen FME; Wouters EFM; Maitland-van der Zee AH; Driessen JHM; de Boer A; de Vries F
Pulm Pharmacol Ther; 2020 Feb; 60():101870. PubMed ID: 31785343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
